Transthyretin cardiac amyloidoses in older North Americans.
about
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisNatural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugsNuclear imaging modalities for cardiac amyloidosisEvolving landscape in the management of transthyretin amyloidosisTransthyretin Cardiac Amyloidosis in Older Americans.New challenges of geriatric cardiology: from clinical to preclinical researchGuideline of transthyretin-related hereditary amyloidosis for clinicians.Cardiac amyloidosis in a heart transplant patient - A case report and retrospective analysis of amyloidosis evolution.Targeting protein aggregation for the treatment of degenerative diseasesSerial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis.Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosesComparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical centerProteotoxicity and cardiac dysfunction.Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.Emerging Advances in the Management of Cardiac Amyloidosis.Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.Case report: senile-onset amyloidosis presenting with painful lower extremity neuropathy.Insights into amyloid disease from fly models.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.Storage diseases with hypertrophic cardiomyopathy phenotype
P2860
Q26764754-C6D49286-1DBC-4018-A261-1A8E73DBB72FQ27009309-624E7551-7D24-4349-B8F3-480D91100F5AQ27024756-1167156B-2A24-406A-888A-33657AA30384Q28086773-2ED03082-9FD9-4230-B50C-8A6774F41E4DQ30244227-7BB0BEA1-9941-4660-B969-D590FAD96C77Q33831628-B6C808C3-B08F-4F0B-B7A7-80161B2CA9F6Q34328734-8DD0104F-B568-43D8-80DB-234A921F83E2Q35066592-2953440E-98AF-4A0D-98EB-C14C82E4B7E3Q36235980-6A98DC9D-B6B8-4DE4-897F-6843466CD58EQ36783800-2F1567F1-0216-4F59-AF4F-F2A23025380EQ36845920-C5DF4553-9E18-4EA1-B179-C39ABAD0079EQ37004163-6A023C11-8C12-40F7-9C82-40B8131E48F0Q37054790-56C95867-3255-4718-BFCE-48AAA2CA6795Q37190740-C7868FA8-80D5-41A6-AF3A-6FED9171417FQ38497014-9B33525F-1DDD-45D3-B4BC-0E38AF2C51B6Q38532386-D4F658C0-1AE6-489C-AC1C-7EC1660FED91Q38587648-521B0EE0-4DBA-4EBC-956A-B0AA42CDDF72Q38720600-54508F2D-2A17-405D-A97B-467796EC9346Q45987839-26182596-11AF-4FE6-8B43-5DF524ED71FFQ46851129-E6B49538-253D-44DF-AE89-BD6968C4AB68Q47561760-E0AC20A8-C94B-486C-8D65-4D020B43191FQ49960443-40D39A59-9A3C-42C6-873E-C80D157A3EF4Q51829619-0311068D-CA21-4908-8C8E-9893CB74449DQ58565558-2C8F9874-751F-4B6F-A08A-F73351A1685D
P2860
Transthyretin cardiac amyloidoses in older North Americans.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Transthyretin cardiac amyloidoses in older North Americans.
@ast
Transthyretin cardiac amyloidoses in older North Americans.
@en
type
label
Transthyretin cardiac amyloidoses in older North Americans.
@ast
Transthyretin cardiac amyloidoses in older North Americans.
@en
prefLabel
Transthyretin cardiac amyloidoses in older North Americans.
@ast
Transthyretin cardiac amyloidoses in older North Americans.
@en
P2860
P1476
Transthyretin cardiac amyloidoses in older North Americans.
@en
P2093
Kumar Dharmarajan
Mathew S Maurer
P2860
P304
P356
10.1111/J.1532-5415.2011.03868.X
P407
P577
2012-02-13T00:00:00Z